DekaBank Deutsche Girozentrale’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,459	Closed	-$541K	–	1398
2020 Q4	$541K	Hold	7,459	–	–	﹤0.01%	1006
2020 Q3	$406K	Hold	7,459	–	–	﹤0.01%	963
2020 Q2	$511K	Hold	7,459	–	–	﹤0.01%	801
2020 Q1	$462K	Hold	7,459	–	–	﹤0.01%	774
2019 Q4	$664K	Hold	7,459	–	–	﹤0.01%	786
2019 Q3	$567K	Sell	7,459 -5,006	-40%	-$406K	﹤0.01%	757
2019 Q2	$1.08M	Buy	+12,465	New	+$1.23M	0.01%	769
2019 Q1	–	Sell	-8,347	Closed	-$725K	–	1264
2018 Q4	$725K	Buy	+8,347	New	+$805K	﹤0.01%	757
2018 Q1	–	Sell	-300	Closed	-$31K	–	1221
2017 Q4	$31K	Hold	300	–	–	﹤0.01%	1026
2017 Q3	$31K	Hold	300	–	–	﹤0.01%	1034
2017 Q2	$34K	Buy	+300	New	+$33.9K	﹤0.01%	1022
2016 Q1	–	Sell	-660	Closed	-$102K	–	1106
2015 Q4	$102K	Buy	+660	New	+$96.4K	﹤0.01%	963

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TARO Position: Q1 2021 in Review

DekaBank Deutsche Girozentrale sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2021, closing a stake of 7,459 shares — an estimated $541K sold.

DekaBank Deutsche Girozentrale first reported a position in TARO in Q4 2015 and held it in 12 quarters. The position peaked at $1.08M in Q2 2019. 80 funds tracked by Wall St. Rank hold TARO as of Q1 2021.

DekaBank Deutsche Girozentrale reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 7,459 Taro Pharmaceutical Industries Ltd. shares in Q1 2021, an estimated $541K.
DekaBank Deutsche Girozentrale first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 12 quarters.
DekaBank Deutsche Girozentrale's Taro Pharmaceutical Industries Ltd. position peaked at $1.08M in Q2 2019.
80 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2021, filed 28 Apr 2021.